Orlando Pride

Orlando Pride Midfielder Luana Diagnosed with Hodgkin’s Lymphoma

The Brazilian has been placed on the Season-Ending Injury List.

Published

on

Image courtesy of Orlando Pride / Mark Thor

The Orlando Pride announced this morning that midfielder Luana has been diagnosed with Hodgkin’s lymphoma, explaining her recent string of excused absences. The Brazilian international has been placed on the Season-Ending Injury list and will immediately begin chemotherapy treatment with the club’s official medical partner, Orlando Health Cancer Institute.   

This news explains Angelina’s celebration on Friday when the midfielder scored her first goal with the Pride. Angelina got onto a ball into the box from Barbra Banda, scored, and made an ‘L’ with her hand. This was obviously a tribute to her teammate both with Orlando and Brazil.

“As a professional athlete I have faced many challenges, on and off the field. I have always fought with courage and determination, and this time will be no different,” Luana said in a club press release. “I really appreciate the support of my family and friends who have strengthened me in this moment. I also want to thank Brazil’s National Team and Orlando Pride for their unconditional support. I kindly ask that my privacy be respected at this time.” 

“On behalf of our club, players, and the entire Orlando community, I want to extend our unwavering commitment to Luana as she begins her treatment,” Orlando Pride Vice President of Soccer Operations and General Manager Haley Carter said in the club’s press release. “We are thankful to have some of the best medical resources available through our partners at Orlando Health, and we are prepared to do all we can to care for Luana in this moment. We fight our battles together, on and off the field, and the Orlando Pride athletes and staff will be side-by-side with Luana and unified in our support of her throughout this process.”

The Pride signed Luana to a two-year deal through 2025 with a club option year for 2026 on Dec. 14, 2023, bringing her in as part of a complete rebuild of the central midfield, which also included the signings of Angelina and Morgan Gautrat. The move has paid early dividends, with only three clubs allowing fewer goals than Orlando through six matches in 2024.

Luana appeared in the team’s first three games (two starts) prior to her diagnosis and played 192 minutes. The the São Paulo, Brazil native, who will turn 31 on Thursday, has yet to contribute a goal or assist, but as a defensive midfielder, that’s not her primary job. She has passed at an 81% success rate, contributing two tackles and three interceptions. Luana has been cautioned twice, committing five fouls, while drawing six on the opposition.

What It Means for Orlando

This news is awful, and the important thing is not how the loss of a player’s services affects the team on the field. It goes beyond that, obviously, and the important thing is that Luana gets the treatment she needs. The hope is that her condition was caught early and that her treatment is successful.

Without Luana available, the club’s depth will be tested throughout 2024. The Pride will hope to get Gautrat healthy and back on the pitch soon, after she has missed the last two matches with a lower leg injury and has been listed as questionable on the availability report. Angelina and Haley McCutcheon have played as the central midfield partnership the last two matches. While the duo has performed well together, especially in the shutout win over San Diego, the team has missed Gautrat’s control on the ball and ability to anticipate what the opposition will do.

On behalf of The Mane Land, I want to wish Luana and her medical team well on her treatment. Although we want to see her back on the pitch, it is far more important that she beats her illness and regains her health.

Trending

Exit mobile version